DK1880718T3 - Farmaceutisk præparat til oral administration med kontrolleret frigivelse af aktivt stof i tyndtarmen og fremgangsmåde til fremstilling deraf - Google Patents

Farmaceutisk præparat til oral administration med kontrolleret frigivelse af aktivt stof i tyndtarmen og fremgangsmåde til fremstilling deraf

Info

Publication number
DK1880718T3
DK1880718T3 DK06014244.5T DK06014244T DK1880718T3 DK 1880718 T3 DK1880718 T3 DK 1880718T3 DK 06014244 T DK06014244 T DK 06014244T DK 1880718 T3 DK1880718 T3 DK 1880718T3
Authority
DK
Denmark
Prior art keywords
preparation
pharmaceutical composition
oral administration
active substance
controlled release
Prior art date
Application number
DK06014244.5T
Other languages
English (en)
Inventor
Gerd Jung
Albert Schaupp
Original Assignee
Pfleger R Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37496994&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1880718(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfleger R Chem Fab filed Critical Pfleger R Chem Fab
Application granted granted Critical
Publication of DK1880718T3 publication Critical patent/DK1880718T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06014244.5T 2006-07-10 2006-07-10 Farmaceutisk præparat til oral administration med kontrolleret frigivelse af aktivt stof i tyndtarmen og fremgangsmåde til fremstilling deraf DK1880718T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06014244A EP1880718B1 (de) 2006-07-10 2006-07-10 Pharmazeutische Zubereitung für die orale Verabreichung mit gesteuerter Wirkstofffreisetzung im Dünndarm und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
DK1880718T3 true DK1880718T3 (da) 2011-11-21

Family

ID=37496994

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06014244.5T DK1880718T3 (da) 2006-07-10 2006-07-10 Farmaceutisk præparat til oral administration med kontrolleret frigivelse af aktivt stof i tyndtarmen og fremgangsmåde til fremstilling deraf

Country Status (21)

Country Link
US (2) US8221787B2 (da)
EP (1) EP1880718B1 (da)
JP (1) JP5424877B2 (da)
KR (1) KR101451233B1 (da)
CN (1) CN101495103B (da)
AR (1) AR061860A1 (da)
AT (1) ATE525065T1 (da)
CA (1) CA2655838C (da)
CL (1) CL2007002000A1 (da)
DK (1) DK1880718T3 (da)
EA (1) EA016683B1 (da)
ES (1) ES2374158T3 (da)
HR (1) HRP20110739T1 (da)
IL (1) IL195931A (da)
JO (1) JO2801B1 (da)
MX (1) MX2009000379A (da)
PL (1) PL1880718T3 (da)
SI (1) SI1880718T1 (da)
TW (1) TWI375573B (da)
UA (1) UA95805C2 (da)
WO (1) WO2008006506A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009130712A2 (en) * 2008-04-22 2009-10-29 Lupin Limited Controlled release pharmaceutical compositions of trospium
EP2133072A1 (en) 2008-06-13 2009-12-16 KRKA, D.D., Novo Mesto Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives
WO2010043408A2 (de) * 2008-10-17 2010-04-22 Ratiopharm Gmbh Mikroverkapseltes fesoterodin
DE102009001636A1 (de) * 2009-03-18 2010-09-23 Henkel Ag & Co. Kgaa Bleichmittel mit verzögertem Bleichbeginn
US20100303920A1 (en) * 2009-05-27 2010-12-02 Johan Hjartstam Aqueous Film Coating Composition / 841
KR20140057604A (ko) * 2011-08-12 2014-05-13 베링거잉겔하임베트메디카게엠베하 고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제
WO2013090893A1 (en) * 2011-12-16 2013-06-20 Celanese Eva Performance Polymers, Inc. Gastroretentive controlled release vehicles that include ethylene copolymers, ethyl celluloses, and/or thermpoplastic polyurethanes
JP2013145174A (ja) * 2012-01-13 2013-07-25 Panasonic Corp 近接センサ
ES2592432T3 (es) * 2013-05-02 2016-11-30 Cardionovum Gmbh Revestimiento de superficie de globo
JP6168673B2 (ja) * 2015-10-07 2017-07-26 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
ITUA20161799A1 (it) * 2016-03-18 2017-09-18 Recordati Ind Chimica E Farmaceutica S P A Composizione farmaceutica a rilascio prolungato comprendente cisteamina o un suo sale
IL303390A (en) 2020-12-03 2023-08-01 Battelle Memorial Institute Compositions of polymer nanoparticles and DNA nanostructures and methods for non-viral transport
WO2022216977A1 (en) 2021-04-07 2022-10-13 Batelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
AU2024393766A1 (en) 2023-12-08 2026-06-18 Battelle Memorial Institute Use of dna origami nanostructures for molecular information based data storage systems
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101344B (fi) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseut tisesti aktiivista ainetta
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
ES2168043B1 (es) 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
JP3888064B2 (ja) * 2000-01-27 2007-02-28 田辺製薬株式会社 徐放性製剤およびその製法
EP1258253A1 (en) * 2000-01-28 2002-11-20 Asahi Kasei Kabushiki Kaisha Novel remedies with the use of beta3 agonist
DE10013029A1 (de) * 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
IN192159B (da) * 2000-05-15 2004-02-28 Ranbaxy Lab Ltd
US7229665B2 (en) * 2001-05-22 2007-06-12 Millipore Corporation Process of forming multilayered structures
TR200300510A2 (tr) * 2003-04-18 2004-11-22 Sanovel �La� Sanay� Ve T�Caret A.�. Dağılan alendronat mikropartikül formülasyonu
US8709476B2 (en) * 2003-11-04 2014-04-29 Supernus Pharmaceuticals, Inc. Compositions of quaternary ammonium compounds containing bioavailability enhancers
DE602004030931D1 (da) * 2003-11-04 2011-02-17 Supernus Pharmaceuticals Inc

Also Published As

Publication number Publication date
MX2009000379A (es) 2009-04-14
TWI375573B (en) 2012-11-01
SI1880718T1 (sl) 2011-11-30
US8221787B2 (en) 2012-07-17
HK1109858A1 (en) 2008-06-27
EA200970100A1 (ru) 2009-06-30
PL1880718T3 (pl) 2012-02-29
EA016683B1 (ru) 2012-06-29
IL195931A0 (en) 2009-09-01
TW200808381A (en) 2008-02-16
KR20090029830A (ko) 2009-03-23
KR101451233B1 (ko) 2014-10-15
UA95805C2 (uk) 2011-09-12
CA2655838A1 (en) 2008-01-17
US20120294938A1 (en) 2012-11-22
CN101495103B (zh) 2013-05-22
EP1880718B1 (de) 2011-09-21
HRP20110739T1 (hr) 2011-11-30
CL2007002000A1 (es) 2008-01-18
JP5424877B2 (ja) 2014-02-26
AR061860A1 (es) 2008-09-24
CA2655838C (en) 2014-04-08
ATE525065T1 (de) 2011-10-15
EP1880718A1 (de) 2008-01-23
US20090285891A1 (en) 2009-11-19
ES2374158T3 (es) 2012-02-14
JP2009542742A (ja) 2009-12-03
WO2008006506A1 (de) 2008-01-17
IL195931A (en) 2014-02-27
CN101495103A (zh) 2009-07-29
JO2801B1 (en) 2014-03-15

Similar Documents

Publication Publication Date Title
IL274602A (en) Pharmaceutical tablets containing eltrombopag olamine, methods for their preparation and use thereof in the preparation of medicaments for treating thrombocytopenia
IL275854A (en) Pharmaceutical composition and its administration
DK2254590T3 (da) Fremgangsmåder og præparater til oral administration af insulin
IL195931A0 (en) Pharmaceutical preparation for oral administration with controlled active ingredient release in the small intestine and methods for its production
DK1940351T3 (da) Formulering af småmolekylære lægemidler med langvarig frigørelse
CU20080052A7 (es) Formas de presentación farmacéutica sólidas de administración oral con liberación rápida de principio activo
DK1986679T3 (da) Fremgangsmåde til forbedring af mikropartiklers farmaceutiske egenskaber omfattende diketopiperazin og et aktivt indholdsstof
MX381895B (es) Formulaciones farmaceuticas de liberacion controlada de nitazoxanida.
DK2001903T3 (da) Langtidsvirkende polypeptider og fremgangsmåder til fremstilling og administration deraf
DK1983964T3 (da) Anordning til indgivelse af lægemiddel
NO20085420L (no) Farmasøytisk formulering med fenylefrin og preparater for absorpsjon i tykktarmen
DK3045043T3 (da) Orale farmaceutiske sammensætninger af 3-hydroxy-n-methylmorphinan med forlænget frigivelse og fremgangsmåde til anvendelse
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
IL188732A (en) Use of ibuprofen and famotidine in the preparation of medicaments
DK3064579T3 (da) Farmaceutiske sammensætninger og medicinske anvendelsesformer af konstruerede humane arginaser
AP2008004447A0 (en) Orally absorbed pharmaceutical formulation and method of administration
IL195491A (en) Pharmaceutical compositions of tmc278 and processes for their preparation
DE602007004119D1 (de) N-(aminoheteroaryl)-1h-indol-2-carboxamid-derivate sowie deren herstellung und therapeutische anwendung
PL2230932T3 (pl) Powlekany preparat farmaceutyczny lub nutraceutyczny o zwiększonym uwalnianiu substancji aktywnej w jelicie grubym
ZA200900423B (en) Methods and medicaments for administration of ibuprofen
PT2129366T (pt) Dose vacinal e farmacêutica sólida
DK1701698T3 (da) Direkte komprimerbart farmaceutisk præparat til oral indgivelse af CCI-779
ZA200908928B (en) Formulations for the oral administration of therapeutic agents and related methods
DK2172207T3 (da) Farmaceutisk sammensætning til behandling af diabetes og fremgangsmåde til fremstilling heraf
EP2185112A4 (en) Stabilized therapeutic compositions and formulations